Terapia personalizada en la enfermedad inflamatoria intestinal

Translated title of the contribution: Personalized therapy in inflammatory bowel disease

Paula Calderón, Paulina Núñez, Pilar Nos, Rodrigo Quera*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Inflammatory bowel diseases (IBD), with ulcerative colitis and Crohn's disease being their most common presentations, comprise a spectrum of diverse disease phenotypes, exhibiting variable behaviors ranging from an indolent course to aggressive phenotypes that impact quality of life of these patients. The last two decades have been marked by the development of new medications (biological therapy and novel small molecules) with diverse mechanisms of action, which have revolutionized the management of IBD, thereby enhancing the quality of life for these patients. This landscape of multiple therapeutic options underscores the need to define which medication will benefit each patient the most and at what speed it should be started. The objective of this review is to present personalized approaches for patients with IBD, thus contributing to therapeutic management.

Translated title of the contributionPersonalized therapy in inflammatory bowel disease
Original languageSpanish
JournalGastroenterologia y Hepatologia
StateAccepted/In press - 2024

Bibliographical note

Publisher Copyright:
© 2023 Elsevier España, S.L.U.


  • Inflammatory bowel diseases
  • Monitoring
  • Personalized
  • Treat to target


Dive into the research topics of 'Personalized therapy in inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this